STOCK TITAN

Ovintiv Inc SEC Filings

OVV NYSE

Welcome to our dedicated page for Ovintiv SEC filings (Ticker: OVV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Ovintiv Inc.'s SEC filings document the formal disclosure record for its oil, NGL and natural gas exploration and production operations in the United States and Canada. Form 8-K reports cover operating and financial results, dividend declarations, completed asset dispositions, acquisition-related financial statements and pro forma information, credit agreement activity, note redemption matters and Regulation FD exhibits.

Proxy and annual-meeting filings describe director elections, board committee assignments, advisory votes on executive compensation, auditor ratification and other shareholder voting matters. The filings also identify the company's common stock registration, capital-structure disclosures, material agreements and risk-factor discussions related to its E&P portfolio and financing activities.

Rhea-AI Summary

FMR LLC filed an amended Schedule 13G/A reporting beneficial ownership of 20,798,631.92 shares of Ovintiv Inc. common stock, or 8.1% of the class, as of 09/30/2025. The filing also lists Abigail P. Johnson as a reporting person.

FMR reports sole voting power over 20,071,470.20 shares and sole dispositive power over 20,798,631.92 shares, with no shared voting or dispositive power. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.

The filing notes that one or more other persons may have rights to dividends or sale proceeds tied to these shares, and no single other person’s interest exceeds five percent of the outstanding common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Ovintiv Inc. reported Q3 2025 results. Total revenues were $2,066 million versus $2,324 million a year ago. Operating income was $273 million versus $527 million. Net earnings were $148 million (diluted EPS $0.57) versus $507 million ($1.92).

For the first nine months, total revenues were $6,761 million versus $6,964 million, with net earnings of $296 million (diluted EPS $1.13) versus $1,185 million. Q3 included $141 million of impairments recorded in Canadian Operations; year‑to‑date impairments totaled $871 million. USA Operations delivered Q3 operating income of $398 million versus $501 million, while Canadian Operations posted a Q3 operating loss of $35 million versus income of $60 million.

Cash from operating activities was $812 million in Q3 and $2,698 million year‑to‑date. Year‑to‑date capital expenditures were $1,682 million; acquisitions used $2,282 million and divestitures provided $1,922 million. The company repurchased $307 million of common shares and paid $232 million in dividends year‑to‑date, including a Q3 dividend of $0.30 per share. Long‑term debt was $4,393 million (current portion $819 million). Shares outstanding were 253.3 million as of September 30, 2025. Ovintiv also reclassified its Market Optimization activities into USA and Canadian segments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
quarterly report
-
Rhea-AI Summary

Ovintiv Inc. reported Q3 2025 results. Total revenues were $2,066 million versus $2,324 million a year ago. Operating income was $273 million versus $527 million. Net earnings were $148 million (diluted EPS $0.57) versus $507 million ($1.92).

For the first nine months, total revenues were $6,761 million versus $6,964 million, with net earnings of $296 million (diluted EPS $1.13) versus $1,185 million. Q3 included $141 million of impairments recorded in Canadian Operations; year‑to‑date impairments totaled $871 million. USA Operations delivered Q3 operating income of $398 million versus $501 million, while Canadian Operations posted a Q3 operating loss of $35 million versus income of $60 million.

Cash from operating activities was $812 million in Q3 and $2,698 million year‑to‑date. Year‑to‑date capital expenditures were $1,682 million; acquisitions used $2,282 million and divestitures provided $1,922 million. The company repurchased $307 million of common shares and paid $232 million in dividends year‑to‑date, including a Q3 dividend of $0.30 per share. Long‑term debt was $4,393 million (current portion $819 million). Shares outstanding were 253.3 million as of September 30, 2025. Ovintiv also reclassified its Market Optimization activities into USA and Canadian segments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
quarterly report
Filing
Rhea-AI Summary

Ovintiv Inc. (OVV) furnished an update on its third‑quarter performance, announcing that it issued a news release with financial and operating results for the quarter ended September 30, 2025, alongside selected and supplemental financial information.

The Board declared a quarterly dividend of $0.30 per share, payable on December 31, 2025 to shareholders of record as of December 15, 2025. The company furnished a news release and supplemental materials as Exhibits 99.1 and 99.2; these materials are furnished under the Exchange Act and not deemed filed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
current report
-
Filing
Rhea-AI Summary

Ovintiv Inc. (OVV) furnished an update on its third‑quarter performance, announcing that it issued a news release with financial and operating results for the quarter ended September 30, 2025, alongside selected and supplemental financial information.

The Board declared a quarterly dividend of $0.30 per share, payable on December 31, 2025 to shareholders of record as of December 15, 2025. The company furnished a news release and supplemental materials as Exhibits 99.1 and 99.2; these materials are furnished under the Exchange Act and not deemed filed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
current report
-
Rhea-AI Summary

Ovintiv Inc. (OVV) announced it has entered into a definitive agreement to acquire NuVista Energy Ltd. in a stock-and-cash transaction. The deal is described as an arrangement and remains subject to customary conditions, including regulatory, court, and NuVista shareholder approvals. The update was furnished under Regulation FD, with additional details provided in an accompanying news release.

The company notes forward-looking risks around completion timing, required approvals, potential distractions to operations, possible legal proceedings, contract consents, and the realization of anticipated benefits and synergies. The disclosure emphasizes that these statements are based on current expectations and are subject to change.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
current report
Rhea-AI Summary

Ovintiv Inc. (OVV) announced it has entered into a definitive agreement to acquire NuVista Energy Ltd. in a stock-and-cash transaction. The deal is described as an arrangement and remains subject to customary conditions, including regulatory, court, and NuVista shareholder approvals. The update was furnished under Regulation FD, with additional details provided in an accompanying news release.

The company notes forward-looking risks around completion timing, required approvals, potential distractions to operations, possible legal proceedings, contract consents, and the realization of anticipated benefits and synergies. The disclosure emphasizes that these statements are based on current expectations and are subject to change.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
current report
-
Rhea-AI Summary

Brendan Michael McCracken, President & CEO and Director of Ovintiv Inc. (OVV), received 1,577 restricted share units (RSUs) on 09/29/2025 as dividend-equivalent RSUs at a $0 price. The filing shows these RSUs are economically equivalent to one share each and will vest and settle per the Omnibus Incentive Plan and the applicable grant agreement, subject to continued employment. After this grant, the reporting person beneficially owns 228,521 shares of common stock. The transaction was reported on Form 4 and executed under the company’s compensation arrangements for executives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Brian Gordon Shaw, a director of Ovintiv Inc. (OVV), acquired 251 Deferred Share Units (DSUs) on 09/29/2025 as dividend equivalents. Each DSU is economically equivalent to one share of Ovintiv common stock and yields dividend-equivalent DSUs. After the reported acquisition the reporting person beneficially owns 36,702 shares of common stock, held in a direct ownership form. DSUs are retained until the director retires from the Board, so these units do not convert into tradable shares immediately but represent future economic interest tied to Ovintiv common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ovintiv director Peter A. Dea received 367 Deferred Share Units (DSUs) on 09/29/2025, each economically equivalent to one share of common stock and including dividend equivalents. These DSUs were issued in lieu of cash dividends for the third quarter of 2025 and are held until the director retires from the board. The reported transaction increased Dea's beneficial ownership to 53,611 shares on a direct basis. The filing was executed by power of attorney and provides no other transactions, cash purchases, sales, or option exercises.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ovintiv Inc. executive Gregory Dean Givens, listed as EVP & COO, acquired 574 Restricted Share Units (RSUs) on 09/29/2025 as reported on a Form 4. Each RSU represents the economic equivalent of one share of Ovintiv common stock and includes dividend-equivalent RSUs. The reported acquisition was priced at $0 (dividend equivalents for Q3 2025 received in lieu of cash) and increased Mr. Givens' total beneficial ownership to 83,097 shares of common stock. The filing was executed by Dawna Gibb under power of attorney on 10/01/2025. Vesting and settlement will follow the company’s Omnibus Incentive Plan and the applicable grant agreement, subject to continued employment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ovintiv Inc. insider filing: Director Ralph Izzo received 39 Deferred Share Units (DSUs) on 09/29/2025, recorded as an acquisition. Each DSU equals one share of Ovintiv common stock and accrues dividend-equivalent DSUs instead of cash dividends. The DSUs are held until the director retires from the board. After this reported transaction, the reporting person beneficially owned 5,718 shares of common stock in a direct ownership form. The Form 4 was filed as a single reporting person filing and executed by a power of attorney on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ovintiv Inc. reported that it has received acceptance from the Toronto Stock Exchange to renew its normal course issuer bid, allowing the company to purchase up to 22,287,709 common shares. The renewed bid covers a 12‑month period starting on October 3, 2025 and ending on October 2, 2026, giving Ovintiv a defined window to buy back its stock. The company furnished a news release with further details as an exhibit, and the information is provided under Regulation FD, meaning it is being shared to keep all investors equally informed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
current report

FAQ

How many Ovintiv (OVV) SEC filings are available on StockTitan?

StockTitan tracks 128 SEC filings for Ovintiv (OVV), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ovintiv (OVV)?

The most recent SEC filing for Ovintiv (OVV) was filed on November 5, 2025.